Why Schrödinger, Inc.’s (SDGR) Stock Is Up 5.66%
As of Wednesday, August 19, Schrödinger, Inc.’s SDGR share price has surged by 5.66%, which has investors questioning if this is right time to sell.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Commentary & Analysis
Is Schrödinger, Inc. (SDGR) Overvalued?
We dive into why Schrödinger, Inc. (SDGR) could be considered overvalued on 2026-08-07, based on AAII’s Value Score and Grade.Tudor Pop
Why Schrödinger, Inc.’s (SDGR) Stock Is Up 8.90%
As of Thursday, August 06, Schrödinger, Inc.’s SDGR share price has surged by 8.90%, which has investors questioning if this is right time to sell.Jenna Brashear
What You Need to Know About Schrödinger, Inc.'s Q3 Earnings
Schrödinger, Inc.'s fiscal Q3 earnings report was released on Wednesday, August 05. Let's dive in to see if (SDGR) missed or beat analyst's expectations.Michael Rose
Why Schrödinger, Inc.’s (SDGR) Stock Is Down 5.16%
As of Thursday, July 16, Schrödinger, Inc.’s SDGR share price has dipped by 5.16%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Financial Summary
| Share Statistics | SDGR | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,464.7 | $200.5 | 50% |
|
| Shares Out (Mil) | 75.8 | 47.8 | 56% |
|
| Institutional Ownership | 97.1% | 79.0% | 72% |
|
| Float (Mil) | 57.3 | 39.8 | 50% |
|
| Beta | 1.66 | 1.17 | 87% |
|
| Avg Daily Volume (000s) | 1,174 | 331 | 73% |
|
| Price Change (52-week) |
0.9% | 44.9% | 46% |
|
| Growth | SDGR | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 18.8% | 11.8% | 79% |
|
| Net Income (5yr) | (33.3%) | 2.7% | 12% |
|
| EPS (5yr) | (28.1%) | 15.5% | 9 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (19.1%) | (15.8%) | 35% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.520) | ($1.830) | ($1.350) | |
| Month Ago EPS | ($0.640) | ($2.250) | ($1.660) | |
| # Rev Up | 2 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | ($0.610) | ($2.225) | ($1.565) | |
| Year/Year Chg | (750.0%) | 29.8% | (35.8%) | |
| Financials | SDGR | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $259 | $202 | 34% |
|
| Net Income (TTM) (Mil) | ($54) | ($9) | 15% |
|
| EPS (TTM) | ($0.734) | ($0.600) | 24% |
|
| Operating Cash Flow (TTM) (Mil) | ($127) | ($1) | 5% |
|
| Net Cash Flow (TTM) (Mil) | $61 | $3 | 72% |
|
| Long-Term Debt (Q1) (Mil) | $92 | $18 | 44% |
|
| Enterprise Value (Q1) (Mil) | $1,025 | $197 | 41% |
|
| Valuation | SDGR | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.34 | 1.38 | 74% |
|
| P/E | na | 39.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.4 | na |
|
| Ratios | SDGR | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 56.9% | 61.6% | 69% |
|
| Net Margin | (21.0%) | (24.1%) | 16% |
|
| ROA | (8.2%) | (21.8%) | 27% |
|
| ROE | (16.2%) | (6.7%) | 25% |
|
| Liabilities to Assets | 48.6% | 32.1% | 40% |
|
| F-Score | 3 | 4 | 18% |
|
Schrödinger, Inc. did not pass any screens on 8/20/2026.
